CN108138146A - 制备原代细胞样品的方法 - Google Patents

制备原代细胞样品的方法 Download PDF

Info

Publication number
CN108138146A
CN108138146A CN201680061008.6A CN201680061008A CN108138146A CN 108138146 A CN108138146 A CN 108138146A CN 201680061008 A CN201680061008 A CN 201680061008A CN 108138146 A CN108138146 A CN 108138146A
Authority
CN
China
Prior art keywords
cell
anoikis
inhibitor
sample
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680061008.6A
Other languages
English (en)
Chinese (zh)
Inventor
L·G·莱恩
B·里驰
A·丹大帕特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celcuity Inc
Original Assignee
Celcuity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celcuity Inc filed Critical Celcuity Inc
Publication of CN108138146A publication Critical patent/CN108138146A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/48—Regulators of apoptosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/73—Hydrolases (EC 3.)
    • C12N2501/734—Proteases (EC 3.4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
CN201680061008.6A 2015-10-20 2016-10-20 制备原代细胞样品的方法 Pending CN108138146A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562243765P 2015-10-20 2015-10-20
US62/243,765 2015-10-20
PCT/US2016/057923 WO2017070353A1 (en) 2015-10-20 2016-10-20 Methods of preparing a primary cell sample

Publications (1)

Publication Number Publication Date
CN108138146A true CN108138146A (zh) 2018-06-08

Family

ID=57233884

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680061008.6A Pending CN108138146A (zh) 2015-10-20 2016-10-20 制备原代细胞样品的方法

Country Status (9)

Country Link
US (2) US11591573B2 (https=)
EP (1) EP3365436B1 (https=)
JP (2) JP7202613B2 (https=)
KR (1) KR102757122B1 (https=)
CN (1) CN108138146A (https=)
AU (1) AU2016341938B2 (https=)
CA (1) CA2999054A1 (https=)
DK (1) DK3365436T3 (https=)
WO (1) WO2017070353A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109402051A (zh) * 2018-12-28 2019-03-01 青岛麦迪赛斯生物科技有限公司 一种人脐带间充质干细胞无血清培养基
CN109777736A (zh) * 2019-01-29 2019-05-21 美闺(长沙)医疗美容有限公司 一种活细胞分析设备及方法
CN109943520A (zh) * 2019-03-08 2019-06-28 北京达博威迎医药技术有限公司 汗腺细胞的分离和培养获得汗腺类器官的方法及其应用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102757122B1 (ko) 2015-10-20 2025-01-21 셀퀴티 인크. 1차 세포 샘플을 제조하는 방법
CN108300688B (zh) * 2018-02-07 2021-02-02 上海赛立维生物科技有限公司 原代肝细胞分离和培养方法
EP4073516A1 (en) 2019-12-09 2022-10-19 Celcuity Inc. Methods of treating cancer patients with ras node or rtk targeted therapeutic agents
CN111733136B (zh) * 2020-06-29 2021-11-30 中山大学孙逸仙纪念医院 一种提高CD90posi细胞分离效率的方法
WO2023074571A1 (ja) 2021-10-27 2023-05-04 住友ベークライト株式会社 ステータ及び構造体

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1795897A1 (fr) * 2005-12-12 2007-06-13 Université de Limoges Test prédictif de réponse thérapeutique du cancer du sein
TW201439537A (zh) * 2012-10-25 2014-10-16 Academia Sinica 用於氧氣濃度控制下同步細胞培養的微流體陣列平台
WO2015089380A2 (en) * 2013-12-12 2015-06-18 Celcuity Llc Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018216A1 (en) 1993-12-30 1995-07-06 Nitta Gelatin Inc. Process for embedding culture of animal cells
US5858678A (en) 1994-08-02 1999-01-12 St. Louis University Apoptosis-regulating proteins
US8252591B2 (en) 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
ATE527341T1 (de) 2004-10-27 2011-10-15 Univ Bruxelles Hepatische differenzierung von stammzellen
EA201070521A1 (ru) * 2007-11-20 2011-02-28 Опито Юниверситер Де Женева Способы идентификации, очистки и обогащения незрелых или стволовых клеток-инициаторов злокачественного роста из опухолей и их применение
WO2010026574A2 (en) 2008-09-02 2010-03-11 Pluristem Ltd. Adherent cells from placenta tissue and use thereof in therapy
US20130012404A1 (en) 2010-01-19 2013-01-10 Osaka Prefectural Hospital Organization Culture method, evaluation method and storage method for cancer-tissue-derived cell mass or aggregated cancer cell mass
EP2566975A4 (en) 2010-05-03 2014-04-02 Microstem Inc SCREENING METHODS, COMPOSITIONS IDENTIFIED BY THIS METHOD, TOOLS USEFUL FOR THEIR IDENTIFICATION AND CELLULAR POPULATIONS THUS PRODUCED
TWI477599B (zh) 2011-01-28 2015-03-21 鴻海精密工業股份有限公司 培育基體
SG11201401183UA (en) * 2011-10-04 2014-09-26 Mitra Biotech Private Ltd Ecm composition, tumor microenvironment platform and methods thereof
US20130330761A1 (en) 2012-06-12 2013-12-12 Celcuity, LLC Whole cell assays and methods
CA2895791A1 (en) * 2013-01-25 2014-07-31 Xcell Biosciences, Inc. Methods, compositions, kits, and systems for selective enrichment of target cells
GB201303491D0 (en) * 2013-02-27 2013-04-10 Cancer Rec Tech Ltd Culture of leukemia initiating cells
WO2015156929A1 (en) * 2014-04-07 2015-10-15 The Trustees Of Columbia University In The City Of New York Method for culture of human bladder cell lines and organoids and uses thereof
KR102757122B1 (ko) 2015-10-20 2025-01-21 셀퀴티 인크. 1차 세포 샘플을 제조하는 방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1795897A1 (fr) * 2005-12-12 2007-06-13 Université de Limoges Test prédictif de réponse thérapeutique du cancer du sein
TW201439537A (zh) * 2012-10-25 2014-10-16 Academia Sinica 用於氧氣濃度控制下同步細胞培養的微流體陣列平台
WO2015089380A2 (en) * 2013-12-12 2015-06-18 Celcuity Llc Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PAOLO PAOLI等: "Anoikis molecular pathways and its role in cancer progression", 《BIOCHIMICA ET BIOPHYSICA ACTA》 *
王艳等: "缺氧微环境对人肺癌高转移细胞株95D失巢凋亡的研究", 《中国医科大学学报》 *
邓正亭等: "自噬与凋亡的相互关系在肿瘤方面的研究进展", 《现代肿瘤医学》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109402051A (zh) * 2018-12-28 2019-03-01 青岛麦迪赛斯生物科技有限公司 一种人脐带间充质干细胞无血清培养基
CN109777736A (zh) * 2019-01-29 2019-05-21 美闺(长沙)医疗美容有限公司 一种活细胞分析设备及方法
CN109943520A (zh) * 2019-03-08 2019-06-28 北京达博威迎医药技术有限公司 汗腺细胞的分离和培养获得汗腺类器官的方法及其应用
CN109943520B (zh) * 2019-03-08 2023-06-23 中国人民解放军军事科学院军事医学研究院 汗腺细胞的分离和培养获得汗腺类器官的方法及其应用

Also Published As

Publication number Publication date
WO2017070353A1 (en) 2017-04-27
AU2016341938A1 (en) 2018-04-26
EP3365436B1 (en) 2021-09-08
JP2018531021A (ja) 2018-10-25
US20180230434A1 (en) 2018-08-16
JP7202613B2 (ja) 2023-01-12
US12215356B2 (en) 2025-02-04
US11591573B2 (en) 2023-02-28
EP3365436A1 (en) 2018-08-29
US20230235293A1 (en) 2023-07-27
DK3365436T3 (da) 2021-10-11
AU2016341938B2 (en) 2022-12-01
JP2021175415A (ja) 2021-11-04
KR20180057653A (ko) 2018-05-30
HK1252635A1 (zh) 2019-05-31
KR102757122B1 (ko) 2025-01-21
CA2999054A1 (en) 2017-04-27

Similar Documents

Publication Publication Date Title
US12215356B2 (en) Methods of preparing a primary cell sample
US11680246B2 (en) Ex vivo proliferation of epithelial cells
JP2018531021A6 (ja) 初代細胞試料を調製する方法
JP2020073602A (ja) ヒト機能性角膜内皮細胞およびその応用
CN103732737A (zh) 用于培养来自正常人输卵管卵巢上皮和人输卵管卵巢肿瘤的细胞的组合物和方法
Kojima et al. Efficient production of trophoblast lineage cells from human induced pluripotent stem cells
EP2188367A2 (en) Hormone responsive tissue culture system and uses thereof
Jin et al. Tropomodulin 3 promotes liver cancer progression by activating the MAPK/ERK signaling pathway
Mizuguchi et al. Three-dimensional spheroid culture induces apical-basal polarity and the original characteristics of immortalized human renal proximal tubule epithelial cells
Gomes-Alves et al. In vitro expansion of human cardiac progenitor cells: exploring'omics tools for characterization of cell-based allogeneic products
WO2019170766A1 (en) Compositions and methods for efficent amplification of retinal progenitors cells
Rodríguez Varela et al. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny
WO2019091013A1 (zh) 一种no供体化合物在制备抑制富含巯基分子的肿瘤细胞的侵袭和转移能力药物中的应用
CN104988116A (zh) 一种化学品胚胎毒性预测模型及其建立方法
HK1252635B (en) Methods of preparing a primary cell sample
Kauss et al. Cardiac cell-derived matrices impart age-specific functional properties to human cardiomyocytes
Hu et al. Directed differentiation of human embryonic stem cells into conjunctival epithelial cells
Ke et al. IGFBP4 suppresses EndMT to maintain corneal endothelial cell characteristics through down-regulating WNT2 to inhibit Wnt2/β-catenin signaling pathway
Stejskalova et al. The scar constituent Collagen I triggers coordinated collective migration and invasion in a 3D spheroid model of early endometriotic lesions
CN104740649A (zh) Plekha5在制备肿瘤诊断试剂中的应用
Bezerra Effectiveness of Hypoxia-Induced Accumulation of Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: American Minnesota

Applicant after: Kelcodi Co., Ltd.

Address before: American Minnesota

Applicant before: Kell Cody